Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

20 Apr, 2017, 03:00 ET Eyevensys Receives Approval From the UK Medicines and Healthcare Products Regulatory Agency to Advance its EyeCET Platform Into Clinical Development

Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables...


20 Apr, 2017, 02:42 ET NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical results demonstrating...


19 Apr, 2017, 19:51 ET First patients at Vanderbilt University Medical Center implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD)

Vanderbilt University Medical Center (VUMC) and EndoStim, Inc., announced that the first patients in Nashville, Tennesse have been implanted with...


19 Apr, 2017, 17:50 ET AbbVie Announces Topline Results from Two Phase 3 Studies Investigating Veliparib in Combination with Chemotherapy for the Treatment of Patients with Advanced or Metastatic Squamous Non-Small Cell Lung Cancer and Early-Stage Triple-Negative Breast Cancer

AbbVie, a global biopharmaceutical company, today announced that two Phase 3 studies evaluating veliparib, an investigational, oral poly (adenosine...


19 Apr, 2017, 17:05 ET NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia

Novartis today announced the publication of a study conducted by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes...


19 Apr, 2017, 16:30 ET Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock

Thermo Fisher Scientific Inc. today announced that results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published...


19 Apr, 2017, 14:20 ET Las Palmas Medical Center First Site in the World To Host Clinical Trial for Fluorescent Imaging Agent Aimed to Prevent Ureter Injuries During Surgery

Las Palmas Medical Center is the first and currently only site in the world to enroll patients in a clinical trial for a fluorescent imaging agent,...


19 Apr, 2017, 14:00 ET Therapeutic Goods Administration Approves AFSTYLA® - CSL Behring's Novel Recombinant Haemophilia A Treatment

Global biotherapeutics leader, CSL Behring today announced that the Australian Therapeutic Goods Administration (TGA) has approved AFSTYLA®...


19 Apr, 2017, 12:14 ET Cannabis-based Medicine May Cut Seizures in Half for Those with Tough-to-treat Epilepsy

Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy, according...


19 Apr, 2017, 11:08 ET First Published Clinical Study Successfully Uses Precision Medicine To Predict Prescription Opioid Abuse

As a Bronze Sponsor of the National Rx Drug Abuse and Heroin Summit, Proove® Biosciences, Inc. announces the first-ever peer-reviewed published...


19 Apr, 2017, 11:05 ET First-of-Its-Kind "SMILE" Vision Surgery Debuts Statewide in Nashville April 21st -- Minimally Invasive New 3D Laser Vision Procedure Being Performed by Nashville's Renowned Dr. Ming Wang

The first major advance in LASIK technology in 20 years, the SMILE procedure, will be performed in Nashville this Friday, April 21, 2017 at Wang...


19 Apr, 2017, 10:36 ET Finding Solutions that Help a Unique Monoclonal Antibody Advance the Fight Against Metastatic Breast Cancer

An important, seminal study was recently published in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal (Revskaya, E, et al. Vol...


19 Apr, 2017, 10:29 ET Center Point Clinical Services Announces New Consensus Guidelines Drafted by KOL Industry Leaders for the Modern Clinical Study Including the Siteless CRO and In-home Clinical Trial

Center Point Clinical Services, creator of the world's first Siteless CRO platform, announced today new consensus guidelines drafted by Key...


19 Apr, 2017, 10:11 ET Scientific Leaders in Renal Research to Give Keynote Talk in Cambridge

Leading renal researchers, Professor Vlado Perkovic and Dr. David Charytan will give a joint talk entitled Ambitious Protocols, Complex Trials and...


19 Apr, 2017, 10:00 ET Avanir Pharmaceuticals to Present Data on NUEDEXTA® and ONZETRA® Xsail® at American Academy of Neurology (AAN) 2017 Annual Meeting

Avanir Pharmaceuticals, Inc. today announced key data presentations for NUEDEXTA® (dextromethorphan hydrobromide/quinidine sulfate) capsules and...


19 Apr, 2017, 09:14 ET GNTbm to begin Phase III clinical trial in Taiwan of epigenetic regulator Chidamide for late-stage breast cancer

GNT Biotech & Medicals Co., Ltd., (GNTbm) (TPEx: 7427) has announced that the anticancer drug Chidamide (HBI-8000), an epigenetic regulator...


19 Apr, 2017, 09:12 ET TSO3 to publish innovative validation method linked to sterilization of multichannel endoscopes in upcoming issue of the Canadian Journal of Infection Control

QUÉBEC CITY, Canada and MYRTLE BEACH, USA, April 19, 2017 /PRNewswire/ - TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical...


19 Apr, 2017, 09:03 ET BrainStorm Announces Publication of NurOwn® Autism Research Study

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...


19 Apr, 2017, 09:00 ET Atomwise Opens Applications for Historic AI Drug Discovery Awards

Atomwise Inc. seeks proposals from innovative university scientists to receive 72 potential medicines, generated specifically for their research by...


19 Apr, 2017, 08:30 ET CytoSorbents 2017 - Propelling the Company to the "Next Level"

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


19 Apr, 2017, 08:05 ET Cantex Pharmaceuticals to Present Overview of CX-02 at the World Orphan Drug Congress

Cantex Pharmaceuticals Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals that improve the treatment of...


19 Apr, 2017, 08:00 ET TFS' Dermatology Team Awarded the Top Job Seal

TFS' fully owned dermatology subsidiary and Centre of Excellence, SCIderm GmbH, has been awarded the Top Job Seal for outstanding employer...


19 Apr, 2017, 08:00 ET Entest BioMedical's Subsidiary, Zander Therapeutics, Inc., Initiates Ex Vivo Studies on Modulating NR2F6 in Canines

Entest BioMedical Inc.'s (OTCPINK: ENTB) subsidiary, Zander Therapeutics, Inc., has contracted with ChemDiv, Inc., an internationally recognized...


19 Apr, 2017, 08:00 ET Boehringer Ingelheim Phase III Study Now Enrolling Patients with Progressive Fibrosing Lung Diseases

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the first patient has been enrolled in the PF-ILD (progressive fibrosing...


19 Apr, 2017, 08:00 ET Ultra-sensitive cancer DNA test dramatically improves patient selection for chemotherapy

MultiGEN Diagnostics announces the publication of an extraordinarily sensitive companion diagnostic methodology for the detection of cancer...